Back to Search
CHRISTOPHER NIGHTINGALE, PHARMD
PHARMD
Pharmacist
NPI: 1568082832Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
5302040909(MI)
Research & Publications (20)
Influence of variable milk quality premiums on observed milk quality.
PMID 18292282·J Dairy Sci·2008
7-preclinical
Ethnic and gender differences in physical activity levels among 9-10-year-old children of white European, South Asian and African-Caribbean origin: the Child Heart Health Study in England (CHASE Study).
PMID 19377098·Int J Epidemiol·2009
4-observational
Blood pressure recording bias during a period when the Quality and Outcomes Framework was introduced.
PMID 19279657·J Hum Hypertens·2009
8-other
Pax7 shows higher satellite cell frequencies and concentrations within intrafusal fibers of muscle spindles.
PMID 18541708·J Histochem Cytochem·2008
7-preclinical
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
PMID 16930925·Diagn Microbiol Infect Dis·2007
4-observational
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients.
PMID 16988206·J Clin Pharmacol·2006
3-trial
In vivo immunomodulatory profile of telithromycin in a murine pneumococcal infection model.
PMID 16649552·Pharmazie·2006
7-preclinical
Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.
PMID 17080381·Infect Control Hosp Epidemiol·2006
8-other
Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients.
PMID 16397286·J Clin Pharmacol·2006
8-other
Tissue penetration of telavancin after intravenous administration in healthy subjects.
PMID 16436747·Antimicrob Agents Chemother·2006
7-preclinical
Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model.
PMID 15894464·Int J Antimicrob Agents·2005
7-preclinical
Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time-kill methodology.
PMID 16144757·Int J Antimicrob Agents·2005
8-other
Future in vitro and animal studies: development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics.
PMID 16305285·Pharmacotherapy·2005
6-review
Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs).
PMID 16024591·J Antimicrob Chemother·2005
8-other
A sensitive assay of amoxicillin in mouse serum and broncho-alveolar lavage fluid by liquid-liquid extraction and reversed-phase HPLC.
PMID 15935600·J Pharm Biomed Anal·2005
7-preclinical
Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem.
PMID 16006272·Pharmacotherapy·2005
4-observational
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
PMID 16002420·J Antimicrob Chemother·2005
3-trial
Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
PMID 16230218·J Infect·2005
8-other
A survey of the quality of generic clarithromycin products from 18 countries.
PMID 17523763·Clin Drug Investig·2005
8-other
Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae.
PMID 16224186·Chemotherapy·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 34300 WOODWARD AVE
BIRMINGHAM, MI 48009 - Phone
- (248) 593-8450
Quick Facts
- NPI
- 1568082832
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile